225 related articles for article (PubMed ID: 15358346)
1. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.
Zou Z; Sun PD
Protein Expr Purif; 2004 Oct; 37(2):265-72. PubMed ID: 15358346
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
3. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
4. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
5. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
6. An improved recombinant mammalian cell expression system for human transforming growth factor-beta2 and -beta3 preparations.
Zou Z; Sun PD
Protein Expr Purif; 2006 Nov; 50(1):9-17. PubMed ID: 16901717
[TBL] [Abstract][Full Text] [Related]
7. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
Yang Y; Dignam JD; Gentry LE
Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986
[TBL] [Abstract][Full Text] [Related]
8. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
9. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
Li Q; Zhou X; Yu J; Qian W; Xu KS
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
[TBL] [Abstract][Full Text] [Related]
10. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
Saharinen J; Taipale J; Keski-Oja J
EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
[TBL] [Abstract][Full Text] [Related]
14. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts.
Budasz-Rwiderska M; Jank M; Motyl T
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():195-214. PubMed ID: 16077203
[TBL] [Abstract][Full Text] [Related]
16. The expression and antigenicity identification of recombinant rat TGF-beta1 in bacteria.
Gao CF; Kong XT; Gressner AM; Weiskirchen R
Cell Res; 2001 Jun; 11(2):95-100. PubMed ID: 11453552
[TBL] [Abstract][Full Text] [Related]
17. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists.
Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS
Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329
[TBL] [Abstract][Full Text] [Related]
18. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]